ANGELA FARO: Open Payments
NPI 1982240586 · NEWBURYPORT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 33 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $868 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $160 |
| Novo Nordisk Inc | 2 | $135 |
| ABBVIE INC. | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $76 |
| Exact Sciences Corporation | 3 | $71 |
| Indivior Inc. | 2 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| ViiV Healthcare Company | 1 | $33 |
Products named: KISUNLA, Ozempic, REXULTI, JARDIANCE, SUBLOCADE, The Cologuard Plus Collection Kit, UBRELVY, LEQVIO.
Industry payments across MA — which companies pay providers there.
